Man Group
IMVT icon

Man Group’s Immunovant IMVT Stock Holding History

Man Group’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.4M Buy
+140,116
New +$4.27M 0.01% 1096
2024
Q4 		– Sell
-109,390
Closed -$3.12M – 2080
2024
Q3 		$3.12M Buy
+109,390
New +$3.23M 0.01% 1181
2024
Q2 		– Sell
-75,920
Closed -$2.45M – 2131
2024
Q1 		$2.45M Sell
75,920
-98,237
-56% -$3.58M 0.01% 1233
2023
Q4 		$7.34M Buy
+174,157
New +$6.41M 0.02% 798
2021
Q1 		– Sell
-8,604
Closed -$397K – 1920
2020
Q4 		$397K Buy
+8,604
New +$398K ﹤0.01% 1599

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Man Group's IMVT Position: Q2 2026 in Review

Man Group opened a new position in Immunovant (IMVT) in Q2 2026: 140,116 shares worth $5.4M. The stake represents 0.01% of the portfolio and ranks #1096 among its holdings. This is a return to the name: Man Group previously reported a position in IMVT as recently as Q3 2024.

Man Group first reported a position in IMVT in Q4 2020 and has held it in 5 quarters since. The position peaked at $7.34M in Q4 2023. 226 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

  • Man Group held 140,116 shares of Immunovant worth $5.4M as of Q2 2026.
  • Immunovant was a new Man Group position in Q2 2026.
  • Immunovant made up 0.01% of Man Group's portfolio in Q2 2026, its #1096 holding.
  • Man Group first reported a position in Immunovant in Q4 2020 and has held it in 5 quarters since.
  • Man Group's Immunovant position peaked at $7.34M in Q4 2023.
  • 226 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.